Component

Chloral hydrate

Context-specific entity; species, compartment and exposure are stated on each claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Five days of 1 g/day chloral hydrate produced detectable dichloroacetate and urinary maleylacetone in healthy volunteers, consistent with inhibition of GSTZ1/MAAI-dependent tyrosine catabolism.

    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    evidence_access
    Primary abstract
    experimental_model
    Eight adults studied at clinical or environmental exposure levels; stable-isotope and metabolite assays.
    limitations
    Environmental-dose plasma DCA was undetectable; direct tissue-enzyme inhibition was inferred from metabolism, not biopsied. No low-dose equivalence is assumed.
    nutrient_topic
    L-Tyrosine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Tyrosine
    plain_language
    A drug metabolite can interfere with an amino-acid disposal enzyme.
    primary_references
    Chloral hydrate, through biotransformation to dichloroacetate, inhibits maleylacetoacetate isomerase and tyrosine catabolism in humans. · 2015 · https://pubmed.ncbi.nlm.nih.gov/25283137/ · DOI 10.1515/dmdi-2014-0015
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    L-Tyrosine: catecholamines, thyroid chemistry, pigment, metabolism and cross-nutrient mechanisms (2026-09-19) · lines 300–306

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Eight adults studied at clinical or environmental exposure levels; stable-isotope and metabolite assays. · source_derived_draft · unverified_draft

    ## l-tyrosine-chloral-gstz A drug metabolite can interfere with an amino-acid disposal enzyme. Five days of 1 g/day chloral hydrate produced detectable dichloroacetate and urinary maleylacetone in healthy volunteers, consistent with inhibition of GSTZ1/MAAI-dependent tyrosine catabolism. Model: Eight adults studied at clinical or environmental exposure levels; stable-isotope and metabolite assays. Limitations: Environmental-dose plasma DCA was undetectable; direct tissue-enzyme inhibition was inferred from metabolism, not biopsied. No low-dose equivalence is assumed. Evidence access: Primary abstract Chloral hydrate, through biotransformation to dichloroacetate, inhibits maleylacetoacetate isomerase and tyrosine catabolism in humans. · 2015 · https://pubmed.ncbi.nlm.nih.gov/25283137/ · DOI 10.1515/dmdi-2014-0015
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards